Skip to content
OpenCapital
Get started

Cocrystal Pharma COCP Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$0.19Beat by $0.03
EPS estimate-$0.22

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$225.0K
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$225.0KIn lineQ4 2024$136.0K

Diluted EPS

Q4 2025-$0.16Miss by $0.01Q1 2026-$0.17Miss by $0.02
Q3 2025-$0.19Beat by $0.03
Q2 2025-$0.20Beat by $0.10Q1 2025-$0.23Beat by $0.29Q4 2024-$0.32Beat by $0.23

Ask the moment Cocrystal Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cocrystal Pharma report Q3 2025 earnings?
Cocrystal Pharma (COCP) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Cocrystal Pharma's Q3 2025 revenue and EPS?
Cocrystal Pharma reported eps of $-0.19 for Q3 2025.
Did Cocrystal Pharma beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.22 by $0.03.
How did Cocrystal Pharma's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 61.2% from $-0.49.
Where can I find Cocrystal Pharma's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022603) and the 10-Q periodic report (0001493152-25-022581) directly on SEC EDGAR. The filing index links above go to sec.gov.